Skip to Main Content
CKG
Home
Home
Home
TKG
Paper Details
Breadcrumb
Paper Details
Paper Title
AZD4320, A Dual Inhibitor of Bcl-2 and Bcl-x<sub>L</sub>, Induces Tumor Regression in Hematologic Cancer Models without Dose-limiting Thrombocytopenia.
PubMed
Paper Journal Title
Clin Cancer Res
Paper Citation Count
36
Paper Publication Year
2020
Bio Mention
AML, AZD4320, Bcl-2, Bcl-2 family members, Bcl-2 prosurvival proteins, Bcl-xL, Hematologic Cancer, Thrombocytopenia, Tumor, acute myeloid leukemia, cancer, cancers, in vitro cell, in vitro cell lines, patient, platelets, thrombocytopenia, tumor, tumor types, tumors, venetoclax
Mesh Descriptor
Animals, Antineoplastic Agents, Apoptosis, Benzamides, Cell Proliferation, Female, Hematologic Neoplasms, Humans, Mice, Mice, Inbred NOD, Mice, SCID, Piperidines, Proto-Oncogene Proteins c-bcl-2, Sulfones, Thrombocytopenia, Tumor Cells, Cultured, Xenograft Model Antitumor Assays, bcl-X Protein
Go
Actions
Author Name
Affiliation
Srividya B Balachander
Oncology R&D
Steven W Criscione
Oncology R&D
Kate F Byth
Oncology R&D
Justin Cidado
Oncology R&D
Ammar Adam
Oncology R&D
Terry MacIntyre
Oncology R&D
Shenghua Wen
Oncology R&D
Deborah Lawson
Oncology R&D
Kathleen Burke
Oncology R&D
Tristan J Lubinski
Oncology R&D
Jeffrey W Tyner
Oncology R&D
Shannon K McWeeney
Knight Cancer Institute, Oregon Health and Science University
Jeffrey G Varnes
Knight Cancer Institute, Oregon Health and Science University
Robert B Diebold
Oncology R&D
Thomas W Gero
Oncology R&D
Stephanos Ioannidis
Oncology R&D
Edward J Hennessy
Oncology R&D
William McCoull
Oncology R&D
Jamal C Saeh
Oncology R&D
Paula Lewis
Oncology R&D
Areya Tabatabai
Oncology R&D
Omid Tavana
Oncology R&D
Nancy Su
Alwin G Schuller
Oncology R&D
Mathew J Garnett
Wellcome Sanger Institute
Patricia Jaaks
Wellcome Sanger Institute
Elizabeth A Coker
Wellcome Sanger Institute
Gareth P Gregory
School of Clinical Sciences at Monash Health, Monash University
Andrea Newbold
Peter MacCallum Cancer Centre
Ricky W Johnstone
Peter MacCallum Cancer Centre
Eric Gangl
Oncology R&D
Martin Wild
Oncology R&D
Michael Zinda
Oncology R&D
J Paul Secrist
Oncology R&D
Barry R Davies
Oncology R&D
Stephen Fawell
Early Oncology R&D
Francis D Gibbons
Oncology R&D
1 - 37
Column Actions
Search
Datasets